Regression of retroperitoneal fibrosis treated by tamoxifen;Régression d'une fibrose rétro-péritonéale traitée par le tamoxifène

Progres en Urologie

Volumn 6, Issue 4, 1996, Pages 578-581

  Devevey, Jean Marc ^a   Michel, Frédéric ^a,d   Chevet, Dominique ^b   Rifle, Gérard ^b   Arnould, Laurent ^c  

^a Service d'Urologie

^b HÔPITAL DU BOCAGE   (France)

^c UNIVERSITÉ DE BOURGOGNE   (France)

^d DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

Antiestrogen; Desmoid tumours; Retroperitoneal fibrosis; Tamoxifen

Indexed keywords

ANTIESTROGEN; TAMOXIFEN;

ADULT; ARTICLE; CASE REPORT; FOLLOW UP; HUMAN; MALE; REMISSION; RETROPERITONEAL FIBROSIS;

ADULT; ESTROGEN ANTAGONISTS; FOLLOW-UP STUDIES; HUMANS; MALE; REMISSION INDUCTION; RETROPERITONEAL FIBROSIS; TAMOXIFEN;

EID: 2842512368     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. BENSON J.R., BAUM M. Tamoxifen for retroperitoneal fibrosis (letter). Lancet, 1993, 341, 836.
2. BROOKS M.D., EBBS S.R., COLLETTA A.A , BAUM M. Desmoid tumors treated with triphenyl ethylenes. Eur. J. of Cancer, 1992, 28A, 1014-1018.
3. BUTTA A , Mc LENNAND K., FLANDERS K.C. Inductionn of TGF β in human breast cancer in vivo following tamoxifen treatment. Cancer Res., 1992, 52, 4261-4262.
4. CLARK C.P . VANDERPOOL D .PRESKITT J. The reponse of retroperitoneal fibrosis to tamoxifen. Surgery 1991, 109, 502-506.
5. FORBES J. Advanced breast cancer and quality of life In : Clinics in Oncology, Philadelphia, W.B. Saunders, 1982, 1, N° 3.
6. GATTEGNO B., HAAB F. Fibrose rétropéritonéale. In : EMC Néphro-Urologie 18162 A 10, 1992.
7. GUILINO A., BARRERA G. Calmomodulin antagonism and growth inhibiting activity of triphemylethylen antioestrogens in MCF-7 human breast cancer cells. Cancer Res., 1986, 46, 6274-6278.
8. MORGAN G., COOKE E. Inhibition of protein kinase C mediated signal transduction by tamoxifen : importance for antitumors activity. Biochem - Pharmacology, 1986, 35, 4463-4465.
9. KINZBRUNNER B., RITTER S., DOMINGO J., ROSENTHAL C.J. Remission of rapidly growing desmoid tumors after tamoxifen therapy. Cancer, 1983, 52, 2201-2204.
10. KROEGER E., BRANDES L. Evidence that tamoxifen is a histamine antagonist. Biochem. Biophys. Res. Comm., 1985, 131, 760-765.
11. LEPOR H., WALSH P. Idiopathic retroperitoneal fibrosis. J. Urol., 1979, 122, 1-6.
12. LIM C., WALKKER W. Estrogen and antioestrogen binding sites in desmoid tumors. Eur. J. Cancer and Clin. Oncol., 1986, 22, 583-587.
13. LOFFELD R.J.L.F., VAN WEEL T.F. Tamoxifen for retroperitoneal fibrosis. Lancet, 1993, 341-382.
14. MATSUDA T., ARAI Y., MUGURUMA K., UCHIDA J., SHICHI Y., KOMATZ Y. Laparoscopic ureterolysis for idiopathic retroperitoneal fibrosis. Eur. Urol., 1994, 26, 286-290.
15. MUKHERJEE A., MALCOLM A , DE LA HUNT M., NEAL D.E. Pelvic fibromatosis (desmoid). Treatment with steroids and tamoxifen. Br. J. Urol., 1995, 75, 559-560.
16. NATO Y. Controlled trial of tamoxifen as single adjuvant agent in the management of early breast cancer. Br. J. Cancer, 1988, 57, 600-611.
17. OWENS L.E , CANCE W.G., HUTH J.F. Retroperitoneal fibrosis treated with tamoxifen Ann Surg., 1995, 61, 842-844.
18. SPILLANE R.M., WHITMAN G.J. Treatment of retroperitoneal fibrosis with tamoxifen. Am. J. Roent., 1995, 164, 515-516.
19. SPORTIELLO D.J., HOOGERLAND D.L. A recurrent pelvic desmoid tumor successfully treated with tamoxifen. Cancer, 1991, 67, 1443-1446.
20. TIMMONS M J. Fibromatosis, desmoids, fibroblasts and tamoxifen. Br. J. PI. Surg., 1994, 47, 378-380.
21. WILCKEN W., TATTERSALL M. Endocrine therapy for desmoid tumors. Cancer, 1991, 68, 1384-1388.
22. YUH W.T.C., BARLOON T.J , SICKELS W.J., KRAMOLOWSKY E.V., WILLIAMS R.D. Magnetic resonance imaging in the diagnosis and follow-up of idiopathic RPF. J. Urol., 1989, 141, 602-605.